Greece
· Delayed Price · Currency is EUR Bioter Statistics
Total Valuation
Bioter has a market cap or net worth of EUR 3.35 million. The enterprise value is 192.65 million.
| Market Cap | 3.35M |
| Enterprise Value | 192.65M |
Important Dates
The last earnings date was Monday, April 28, 2025.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioter has 16.73 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 16.73M |
| Shares Outstanding | 16.73M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.67 |
| PB Ratio | -0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.06 |
| EV / Sales | 153.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.98 |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -15.82 |
| Interest Coverage | -1.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -10.10% |
| Return on Invested Capital (ROIC) | -13.14% |
| Return on Capital Employed (ROCE) | 8.92% |
| Revenue Per Employee | 251,000 |
| Profits Per Employee | -4.25M |
| Employee Count | 4 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 2.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.71% in the last 52 weeks. The beta is 0.76, so Bioter's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -25.71% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 47.58 |
| Average Volume (20 Days) | 4,752 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioter had revenue of EUR 1.26 million and -21.26 million in losses. Loss per share was -1.27.
| Revenue | 1.26M |
| Gross Profit | 958,000 |
| Operating Income | -11.99M |
| Pretax Income | -22.15M |
| Net Income | -21.26M |
| EBITDA | -11.90M |
| EBIT | -11.99M |
| Loss Per Share | -1.27 |
Balance Sheet
The company has 986,000 in cash and 190.60 million in debt, giving a net cash position of -189.62 million or -11.33 per share.
| Cash & Cash Equivalents | 986,000 |
| Total Debt | 190.60M |
| Net Cash | -189.62M |
| Net Cash Per Share | -11.33 |
| Equity (Book Value) | -139.43M |
| Book Value Per Share | -8.31 |
| Working Capital | -178.02M |
Cash Flow
In the last 12 months, operating cash flow was -11.84 million and capital expenditures -214,000, giving a free cash flow of -12.05 million.
| Operating Cash Flow | -11.84M |
| Capital Expenditures | -214,000 |
| Free Cash Flow | -12.05M |
| FCF Per Share | -0.72 |
Margins
| Gross Margin | 76.33% |
| Operating Margin | -955.70% |
| Pretax Margin | -1,764.78% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bioter does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | -635.15% |
| FCF Yield | -360.09% |
Stock Splits
The last stock split was on August 9, 2010. It was a reverse split with a ratio of 0.25.
| Last Split Date | Aug 9, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |